Haleon sets 8.80B voting shares for FCA thresholds
Haleon plc (HLN) reported its total voting rights and share capital as of 31 August 2026.
Rhea-AI Filing Summary
Haleon plc (HLN) reported its total voting rights and share capital as of 31 August 2026. The company has 8,808,341,409 ordinary shares of £0.01 each in issue, of which 11,792,625 shares are held as treasury shares. This results in 8,796,548,784 ordinary shares with voting rights, which shareholders and other obliged investors should use as the denominator when calculating whether they must notify interests or changes in interests under the FCA's Disclosure Guidance and Transparency Rules.
Positive
- None.
Negative
- None.
Key Figures
Total ordinary shares issued: 8,808,341,409 shares
Treasury shares: 11,792,625 shares
Ordinary shares with voting rights: 8,796,548,784 shares
+2 more
5 metrics
Total ordinary shares issued
8,808,341,409 shares
As at 31 August 2026
Treasury shares
11,792,625 shares
Ordinary shares of £0.01 each held as treasury shares as at 31 August 2026
Ordinary shares with voting rights
8,796,548,784 shares
Denominator for disclosure calculations under FCA rules as at 31 August 2026
Ordinary share nominal value
£0.01 per share
Nominal value of each ordinary share of Haleon plc
Filing date
01 September 2026
Date of the total voting rights and capital announcement
Key Terms
treasury shares, voting rights, Disclosure Guidance and Transparency Rules, notifiable interests, +1 more
5 terms
voting rights financial
"Therefore, the number of ordinary shares with voting rights is 8,796,548,784"
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
Disclosure Guidance and Transparency Rules regulatory
"under the FCA's Disclosure Guidance and Transparency Rules"
Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.
notifiable interests regulatory
"Notifiable interests in Haleon may be sent to:"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
FAQ
What type of company is Haleon plc (HLN) and what markets is it listed on?
Haleon plc is described as a consumer company focused on better everyday health and is listed on the LSE and NYSE under the symbol HLN. Its brands include Advil, Centrum, Sensodyne, Panadol, Theraflu and others.
AI-generated analysis. How Rhea-AI works. Not financial advice.
